ABI
IONS icon

Adamant Biomedical Investments’s Ionis Pharmaceuticals IONS Stock Holding History

Adamant Biomedical Investments’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$6.17M Sell
100,000
-40,000
-29% -$1.97M 1.48% 22
2014
Q3 		$5.44M Buy
+140,000
New +$4.96M 1.36% 23

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adamant Biomedical Investments's IONS Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its Ionis Pharmaceuticals (IONS) stake by 29% in Q4 2014, selling an estimated $1.97M and leaving 100,000 shares worth $6.17M. The position accounts for 1.48% of the portfolio, ranked #22.

Adamant Biomedical Investments first reported a position in IONS in Q3 2014 and has held it in 2 quarters since. 285 funds tracked by Wall St. Rank hold IONS as of Q4 2014.

  • Adamant Biomedical Investments held 100,000 shares of Ionis Pharmaceuticals worth $6.17M as of Q4 2014.
  • Adamant Biomedical Investments sold 40,000 Ionis Pharmaceuticals shares in Q4 2014, an estimated $1.97M.
  • Ionis Pharmaceuticals made up 1.48% of Adamant Biomedical Investments's portfolio in Q4 2014, its #22 holding.
  • Adamant Biomedical Investments first reported a position in Ionis Pharmaceuticals in Q3 2014 and has held it in 2 quarters since.
  • 285 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.